Cargando…
Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions
The sale of unproven stem cell interventions (SCIs) by commercial entities has proliferated in highly developed countries, most notably in the USA. Yet, there have been few criminal prosecutions and regulatory enforcement actions against providers who have violated laws and best practice standards d...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818472/ https://www.ncbi.nlm.nih.gov/pubmed/29479481 http://dx.doi.org/10.1038/s41536-018-0043-6 |